Letourneau J

ORCID: 0000-0001-9966-5851 · 2 papers in corpus · active 2021-2025
2025
Breast Cancer Is Increased in Women With Primary Ovarian Insufficiency.
The Journal of clinical endocrinology and metabolism ·doi:10.1210/clinem/dgae480

ContextDNA damage/repair gene variants are associated with both primary ovarian insufficiency (POI) and cancer risk.ObjectiveWe hypothesized that a subset of women with POI and family members would have increased risk for cancer.DesignCase-…

2021
Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial.
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-021-02273-3

PurposeTo determine whether concomitant tamoxifen 20 mg with gonadotropins (tamoxifen-gonadotropin) versus letrozole 5 mg with gonadotropins (letrozole-gonadotropin) affects mature oocyte yield.MethodsOpen-label, single-institution, randomi…